Lantheus Medical Imaging, Inc.

Lantheus Medical Imaging (www.lantheus.com), a global leader in developing, manufacturing and distributing innovative diagnostic imaging agents, is dedicated to creating and providing pioneering medical imaging solutions to improve the treatment of human disease. Lantheus products include leading cardiac imaging brands Cardiolite® (Kit for the Preparation of Technetium Tc99m Sestamibi for Injection); DEFINITY® Vial for (Perflutren Lipid Microsphere) Injectable Suspension; and TechneLite® (Technetium Tc99m Generator). Lantheus also provides ABLAVAR® (gadofosveset trisodium), a first-in-class blood pool contrast agent for magnetic resonance angiography. Lantheus has approximately 600 employees worldwide with headquarters in North Billerica, Massachusetts, and offices in Puerto Rico, Canada and Australia.